Immunotherapeutic effects of chitin in comparison with chitosan against Leishmania major infection

Parasitology International

Volumn 65, Issue 2, 2016, Pages 99-104

  Hoseini, Mostafa Haji Molla ^a   Moradi, Maryam ^a   Alimohammadian, Mohammad Hossein ^b   Shahgoli, Vahid Khaze ^b   Darabi, Hayedeh ^b   Rostami, Ali ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Chitin; Chitosan; Immunotherapeutic effect; Leishmania major

Indexed keywords

CHITIN; CHITOSAN; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DILUTION; DNA SYNTHESIS; FEMALE; IMMUNOTHERAPY; LEISHMANIASIS; LYMPH NODE CELL; MOUSE; NONHUMAN; PARASITE LOAD; PRIORITY JOURNAL; SKIN DEFECT; TREATMENT DURATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; COMPARATIVE STUDY; CYTOLOGY; IMMUNOLOGY; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPH NODE; PARASITOLOGY; PHYSIOLOGY; SKIN ABSORPTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL PROLIFERATION; CHITIN; CHITOSAN; CYTOKINES; FEMALE; IMMUNOTHERAPY; INTERFERON-GAMMA; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; MICE, INBRED BALB C; PARASITE LOAD; SUBCUTANEOUS ABSORPTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84947811139     PISSN: 13835769     EISSN: 18730329     Source Type: Journal    
DOI: 10.1016/j.parint.2015.10.007     Document Type: Article

References (43)

1. Karami M., Doudi M., Setorki M. Assessing epidemiology of cutaneous leishmaniasis in Isfahan, Iran. J. Vector Borne Dis. 2013, 50:30-37.
2. Rajasekaran R., Chen Y.P. Potential therapeutic targets and the role of technology in developing novel antileishmanial drugs. Drug Discov. Today 2015, 20:958-968.
3. Fernandez J.G., Ingber D.E. manufacturing of large-scale functional objects using biodegradable chitosan bioplastic. Macromol. Mater. Eng. 2014, 299:932-938.
4. Badwan A.A., Rashid I., Omari M.M., Darras F.H. Chitin and chitosan as direct compression excipients in pharmaceutical applications. Mar. Drugs 2015, 19:1519-1547.
5. Nishimura K., Nishimura S., Nishi N., Saiki I., Tokura S., Azuma I. Immunological activity of chitin derivatives. Vaccine 1984, 2:93-99.
6. Lee C.G., Da Silva C.A., Lee J.-Y., Hartl D., Elias J.A. Chitin regulation of immune responses: an old molecule with new roles. Curr. Opin. Immunol. 2008, 20:684-689.
7. Da Silva C.A., Chalouni C., Williams A., Hartl D., Lee C.G., Elias J.A. Chitin is a size dependent regulator of macrophage TNF and IL-10 production. J. Immunol. 2009, 182:3573-3582.
8. Da Silva C.A., Hartl D., Liu W., Lee C.G., Elias J.A. TLR-2 and IL-17A in chitininduced macrophage activation and acute inflammation. J. Immunol. 2008, 181:4279-4286.
9. Dehghani F., Hoseini M.H.M., Memarnejadian A., Yeganeh F., Rezaie A.M., Khaze V., Sattari M., Tamijani H.D., Labibi F., Mossaffa N. Immunomodulatory activities of chitin microparticles on leishmania major-infected murine macrophages. Arch. Med. Res. 2011, 42:572-576.
10. Kim S.K., Venkatesan J. Chitin and chitosan derivatives. Chitin and chitosan derivatives advances in drug discovery and developments. 2014, 3-15. CRC press, London. S.K.,. Kim (Ed.).
11. Shibata Y., Honda I., Justice J.P., Van Scott M.R., Nakamura R.M., Myrvik Q.N. Th1 adjuvant N-acetyl-D-glucosamine polymer up-regulates Th1 immunity but downregulates Th2 immunity against a mycobacterial protein (MPB-59) in interleukin-10- knockout and wild-type mice. Infect. Immun. 2001, 69:6123-6130.
12. Koch B.E., Stougaard J., Spaink H.P. Keeping track of the growing number of biological functions of chitin and its interaction partners in biomedical research. Glycobiology 2015, 25:469-482.
13. Strong P., Clark H., Reid K. Intranasal application of chitin microparticles down-regulates symptoms of allergic hypersensitivity to dermatophagoides pteronyssinus and Aspergillus fumigatus in murine models of allergy. Clin. Exp. Allergy 2002, 32:1794-1800.
14. Bueter C.L., Lee C.K., Rathinam V.A., Healy G.J., Taron C.H., Specht C.A., Levitz S.M. Chitosan but not chitin activates the inflammasome by a mechanism dependent upon phagocytosis. J. Biol. Chem. 2011, 286:35447-35455.
15. Bueter C.L., Lee C.K., Wang J.P., Ostroff G.R., Specht C.A., Levitz S.M. Spectrum and mechanisms of inflammasome activation by chitosan. J. Immunol. 2014, 192:5943-5951.
16. Ghotloo S., Hoseini M.H.M., Alimohammadian M.H., Khaze V., Memarnejadian A., Rostami A. Immunomodulatory effects of chitin microparticles on leishmania majorinfected BALB/c mice. Parasitol. Int. 2015, 64:219-221.
17. Lima H., Bleyenberg J., Titus R. A simple method for quantifying leishmania in tissues of infected animals. Parasitol. Today 1997, 13:80-82.
18. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. III. Validity tests for the single-hit Poisson model. J. Immunol. Methods 1984, 72:29-40.
19. Yeganeh F., Barkhordari F., Omidi M., Samiei A., Adeli A., Mahboudi F., Kamali-Sarvestani E. Cloning and expression of leishmania major superoxide dismutase B1: a potential target antigen for serodiagnosis of leishmaniasis. Iran. J. Immunol. 2009, 6:130-140.
20. Kaye P., Scott P. Leishmaniasis: complexity at the host-pathogen interface. Nat. Rev. Microbiol. 2011, 9:604-615.
21. Gonzalez-Lombana C., Gimblet C., Bacellar O., Oliveira W.W., Passos S., Carvalho L.P., Goldschmidt M., Carvalho E.M., Scott P. IL-17 mediates immunopathology in the absence of IL-10 following leishmania major infection. PLoS Pathog. 2013, 9.
22. Faria M.S., Calegari-Silva T.C., Carvalho Vivarini A., Mottram J.C., Lopes U.G., Lima A.P. Role of protein kinase R in the killing of leishmania major by macrophages in response to neutrophil elastase and TLR4 via TNFα and IFNβ. FASEB J. 2014, 28:3050-3063.
23. Otterlei M., Vhrumt K.M., Ryan L., Espevik T. Characterization of binding and TNF- -inducing ability of chitosans on monocytes: the involvement of CD14. Vaccine 1994, 12:825-832.
24. Chen C.L., Wang Y.M., Liu C.F., Wang J.Y. the effect of water-soluble chitosan on macrophage activation and the attenuation of mite allergen-induced airway inflammation. Biomaterials 2008, 29:2173-2182.
25. Azuma K., Osaki T., Minami S., Okamoto Y. Anticancer and anti-inflammatory properties of chitin and chitosan oligosaccharides. J. Funct. Biomater. 2015, 6:33-49.
26. Kim M.S., You H.J., You M.K., Kim N.S., Shim B.S., Kim H.M. Inhibitory effect of water-soluble chitosan on TNF-alpha and IL-8 secretion from HMC-1 cells. Immunopharmacol. Immunotoxicol. 2004, 26:401-409.
27. Zhu J., Zhang Y., Wu G., Xiao Z., Zhou H., Yu X. Inhibitory effects of oligochitosan on TNF-α, IL-1β and nitric oxide production in lipopolysaccharide-induced RAW264.7 cells. Mol. Med. Rep. 2015, 11:729-733.
28. Marincola F.M. Interleukin-10, Landes Bioscience Georgetown 2006.
29. Wagener J., Malireddi R.S., Lenardon M.D., Köberle M., Vautier S., MacCallum D.M., Biedermann T., Schaller M., Netea M.G., Kanneganti T.-D. Fungal chitin dampens inflammation through IL-10 induction mediated by NOD2 and TLR9 activation. PLoS Pathog. 2014, 10.
30. Kogiso M., Nishiyama A., Shinohara T., Nakamura M., Mizoguchi E., Misawa Y., Guinet E., Nouri-Shirazi M., Dorey C.K., Henriksen R.A., Shibata Y. Chitin particles induce size-dependent but carbohydrate-independent innate eosinophilia. J. Leukoc. Biol. 2011, 90:167-176.
31. Liu D., Uzonna J.E. The early interaction of leishmania with macrophages and dendritic cells and its influence on the host immune response. Front. Cell. Infect. Microbiol. 2012, 2:83.
32. Shibata Y., Metzger W.J., Myrvik Q.N. Chitin particle-induced cell-mediated immunity is inhibited by soluble mannan: mannose receptor-mediated phagocytosis initiates IL-12 production. J. Immunol. 1997, 159:2462-2467.
33. Ji Q., Deng J., Yu X., Xu Q., Wu H., Pan J. Modulation of pro-inflammatory mediators in LPS-stimulated human periodontal ligament cells by chitosan and quaternized chitosan. Carbohydr. Polym. 2013, 92:824-829.
34. Nagatani K., Wang S., Llado V., Lau C.W., Li Z., Mizoguchi A., Nagler C.R., Shibata Y., Reinecker H.C., Mora J.R. Chitin microparticles for the control of intestinal inflammation. Inflamm. Bowel Dis. 2012, 18:1698-1710.
35. Nishimura K., Nishimura S., Nishi N., Numata F., Tone Y., Tokura S., Azuma L. Adjuvant activity of chitin derivatives in mice and guinea-pigs. Vaccine 1985, 3:379-384.
36. Jiang M., Ouyang H., Ruan P., Zhao H., Pi Z., Huang S., Yi P., Crepin M. Chitosan derivatives inhibit cell proliferation and induce apoptosis in breast cancer cells. Anticancer Res. 2011, 31:1321-1328.
37. Howling G.I., Dettmar P.W., Goddard P.A., Hampson F.C., Dornish M., Wood E.J. The effect of chitin and chitosan on the proliferation of human skin fibroblasts and keratinocytes in vitro. Biomaterials 2011, 22:2959-2966.
38. Komlos L., Ben-efraim S., Lewis'i N.J., Hart J., Halbrecht I., S Effect of n-acetyl-d-glucosamine (nag) on mitogenic, antigenic and allogeneic stimulation of normal human lymphocytes. Int. J. lmraunopharmac. 1984, 6:593-599.
39. Korolenko T., Zhanaeva S.Y., Falameeva O., Kaledin V., Filyushina E., Buzueva I., Paul G. Chitotriosidase as a marker of macrophage stimulation. Bull. Exp. Biol. Med. 2000, 130:948-950.
40. van Eijk M., van Roomen C.P., Renkema G.H., Bussink A.P., Andrews L., Blommaart E.F., Sugar A., Verhoeven A.J., Boot R.G., Aerts J.M. Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity. Int. Immunol. 2005, 17:1505-1512.
41. Zimmerman J.R. The Characterization of Chitin Microparticle Preparations: Degree of Acetylation and its Effect on Immunologic Response 2014, 59. (Masters Theses Accessible in: http://scholarworks.umass.edu/masters_theses_2/59).
42. Riccardo A., Muzzarelli A. Chitins and chitosans as immunoadjuvants and Non-allergenic drug carriers. Mar. Drugs 2010, 8:292-312.
43. Okawa Y., Kobayashi M., Suzuki S., Suzuki M. Comparative study of protective effects of chitin, chitosan, and N-acetyl chitohexaose against Pseudomonas aeruginosa and Listeria monocytogenes infections in mice. Biol. Pharm. Bull. 2003, 26:902-904.